The Biologic Syndrome of Frailty in Heart Failure

The Biologic Syndrome of Frailty in Heart Failure

Show other versions (1)

As we continue to care for an older and sicker end-stage heart failure population, it has become challenging to evaluate patients based on current risk scores that mainly focus on subjective symptoms and patient disability. For generations, geriatricians have sought to identify the body's under...

Full description

Bibliographic Details
Main Authors: Rita Jermyn, Snehal Patel
Format: Article
Language:English
Published: SAGE Publishing 2014-01-01
Series:Clinical Medicine Insights: Cardiology
Online Access:https://doi.org/10.4137/CMC.S15720
id doaj-86a6eec8677c4f1c8c49b15f3586b079
record_format Article
spelling doaj-86a6eec8677c4f1c8c49b15f3586b0792020-11-25T03:22:59ZengSAGE PublishingClinical Medicine Insights: Cardiology1179-54682014-01-018s110.4137/CMC.S15720The Biologic Syndrome of Frailty in Heart FailureRita Jermyn0Snehal Patel1Division of Heart Failure, Department of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.Division of Heart Failure, Department of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.As we continue to care for an older and sicker end-stage heart failure population, it has become challenging to evaluate patients based on current risk scores that mainly focus on subjective symptoms and patient disability. For generations, geriatricians have sought to identify the body's underlying vulnerabilities that characterize frailty. More recently, cardiologists have begun to recognize this entity in their own practice. Several studies have suggested rates of frailty as high as 50% in patients with cardiovascular disease. However, despite recognizing frailty, it remains difficult to define. Like heart failure, frailty is a biologic syndrome that affects multiple organ systems. Measures of frailty are shown to strongly correlate with adverse outcomes in the health care system.https://doi.org/10.4137/CMC.S15720
collection DOAJ
language English
format Article
sources DOAJ
author Rita Jermyn
Snehal Patel
spellingShingle Rita Jermyn
Snehal Patel
The Biologic Syndrome of Frailty in Heart Failure
Clinical Medicine Insights: Cardiology
author_facet Rita Jermyn
Snehal Patel
author_sort Rita Jermyn
title The Biologic Syndrome of Frailty in Heart Failure
title_short The Biologic Syndrome of Frailty in Heart Failure
title_full The Biologic Syndrome of Frailty in Heart Failure
title_fullStr The Biologic Syndrome of Frailty in Heart Failure
title_full_unstemmed The Biologic Syndrome of Frailty in Heart Failure
title_sort biologic syndrome of frailty in heart failure
publisher SAGE Publishing
series Clinical Medicine Insights: Cardiology
issn 1179-5468
publishDate 2014-01-01
description As we continue to care for an older and sicker end-stage heart failure population, it has become challenging to evaluate patients based on current risk scores that mainly focus on subjective symptoms and patient disability. For generations, geriatricians have sought to identify the body's underlying vulnerabilities that characterize frailty. More recently, cardiologists have begun to recognize this entity in their own practice. Several studies have suggested rates of frailty as high as 50% in patients with cardiovascular disease. However, despite recognizing frailty, it remains difficult to define. Like heart failure, frailty is a biologic syndrome that affects multiple organ systems. Measures of frailty are shown to strongly correlate with adverse outcomes in the health care system.
url https://doi.org/10.4137/CMC.S15720
work_keys_str_mv AT ritajermyn thebiologicsyndromeoffrailtyinheartfailure
AT snehalpatel thebiologicsyndromeoffrailtyinheartfailure
AT ritajermyn biologicsyndromeoffrailtyinheartfailure
AT snehalpatel biologicsyndromeoffrailtyinheartfailure
_version_ 1724608460282134528

Similar Items